Your browser doesn't support javascript.
loading
Current phenotypic and genetic spectrum of syndromic deafness in Tunisia: paving the way for precision auditory health.
Mkaouar, Rahma; Riahi, Zied; Marrakchi, Jihene; Mezzi, Nessrine; Romdhane, Lilia; Boujemaa, Maroua; Dallali, Hamza; Sayeb, Marwa; Lahbib, Saida; Jaouadi, Hager; Boudabbous, Hela; Zekri, Lotfi; Chargui, Mariem; Messaoud, Olfa; Elyounsi, Meriem; Kraoua, Ichraf; Zaouak, Anissa; Turki, Ilhem; Mokni, Mourad; Boucher, Sophie; Petit, Christine; Giraudet, Fabrice; Mbarek, Chiraz; Besbes, Ghazi; Halayem, Soumeyya; Zainine, Rim; Turki, Hamida; Tounsi, Amel; Bonnet, Crystel; Mrad, Ridha; Abdelhak, Sonia; Trabelsi, Mediha; Charfeddine, Cherine.
Afiliación
  • Mkaouar R; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Riahi Z; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Marrakchi J; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Mezzi N; Department of Otorhinolaryngology, District Hospital of Menzel Bourguiba, Bizerte, Tunisia.
  • Romdhane L; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Boujemaa M; Department of Biology, Faculty of Sciences of Bizerte, Université Tunis Carthage, Tunis, Tunisia.
  • Dallali H; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Sayeb M; Department of Biology, Faculty of Sciences of Bizerte, Université Tunis Carthage, Tunis, Tunisia.
  • Lahbib S; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Jaouadi H; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Boudabbous H; Genetic Typing Service, Institut Pasteur of Tunis, Tunis, Tunisia.
  • Zekri L; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Chargui M; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Messaoud O; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Elyounsi M; Marseille Medical Genetics (MMG) U1251, Aix Marseille Université, INSERM, Marseille, France.
  • Kraoua I; Department of Pediatrics, La Rabta Hospital, Tunis, Tunisia.
  • Zaouak A; Laboratory of Hereditary Diseases of the Metabolism Investigation and Patients Management, Faculty of Medicine in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Turki I; Department of Epidemiology and Public Health, Directorate General of Military Health, Faculty of Medicine in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Mokni M; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Boucher S; ICHARA Association (International Research Institute on Sign Language), Tunis, Tunisia.
  • Petit C; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Giraudet F; Laboratory of Biomedical Genomics and Oncogenetics LR16IPT05, Pasteur Institute in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Mbarek C; Department of Congenital and Hereditary Diseases, Charles Nicolle Hospital in Tunis, Tunis, Tunisia.
  • Besbes G; LR99ES10 Laboratory of Human Genetics, Faculty of Medicine in Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Halayem S; Child and Adolescent Neurology Department of Neurology, National Institute of Neurology, Tunis, Tunisia.
  • Zainine R; LR18SP04 Department of Child Neurology, National Institute Mongi Ben Hmida of Neurology in Tunis. University of Tunis El Manar, Tunis, Tunisia.
  • Turki H; Department of Dermatology, Habib Thameur Hospital, Research Unit Genodermatoses and Cancers LR12SP03, Tunis, Tunisia.
  • Tounsi A; Child and Adolescent Neurology Department of Neurology, National Institute of Neurology, Tunis, Tunisia.
  • Bonnet C; LR18SP04 Department of Child Neurology, National Institute Mongi Ben Hmida of Neurology in Tunis. University of Tunis El Manar, Tunis, Tunisia.
  • Mrad R; Service de dermatologie, Hôpital La Rabta, Unité de recherche UR 12SP07, Hôpital La Rabta, Tunis, Tunisia.
  • Abdelhak S; Service d'ORL et chirurgie cervico-faciale, CHU d'Angers, Angers, France.
  • Trabelsi M; Equipe Mitolab, Institut Mitovasc, CNRS UMR6015, UMR Inserm 1083, Université d'Angers, Angers, France.
  • Charfeddine C; Institut Pasteur, Université Paris Cité, Inserm UA06, Institut de l'Audition, Paris, France.
Front Genet ; 15: 1384094, 2024.
Article en En | MEDLINE | ID: mdl-38711914
ABSTRACT
Hearing impairment (HI) is a prevalent neurosensory condition globally, impacting 5% of the population, with over 50% of congenital cases attributed to genetic etiologies. In Tunisia, HI underdiagnosis prevails, primarily due to limited access to comprehensive clinical tools, particularly for syndromic deafness (SD), characterized by clinical and genetic heterogeneity. This study aimed to uncover the SD spectrum through a 14-year investigation of a Tunisian cohort encompassing over 700 patients from four referral centers (2007-2021). Employing Sanger sequencing, Targeted Panel Gene Sequencing, and Whole Exome Sequencing, genetic analysis in 30 SD patients identified diagnoses such as Usher syndrome, Waardenburg syndrome, cranio-facial-hand-deafness syndrome, and H syndrome. This latter is a rare genodermatosis characterized by HI, hyperpigmentation, hypertrichosis, and systemic manifestations. A meta-analysis integrating our findings with existing data revealed that nearly 50% of Tunisian SD cases corresponded to rare inherited metabolic disorders. Distinguishing between non-syndromic and syndromic HI poses a challenge, where the age of onset and progression of features significantly impact accurate diagnoses. Despite advancements in local genetic characterization capabilities, certain ultra-rare forms of SD remain underdiagnosed. This research contributes critical insights to inform molecular diagnosis approaches for SD in Tunisia and the broader North-African region, thereby facilitating informed decision-making in clinical practice.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Genet Año: 2024 Tipo del documento: Article País de afiliación: Túnez

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Genet Año: 2024 Tipo del documento: Article País de afiliación: Túnez